E
ENDRA Life Sciences Inc.
NDRA
$3.57
$0.1253.63%
E
Sell
12/20/2024Upgraded
ENDRA Life Sciences Inc. (NDRA) was upgraded to E+ from E on 12/20/2024 due to an increase in the volatility index and total return index.
ENDRA Life Sciences Inc. (NDRA) was upgraded to E+ from E on 12/20/2024 due to an increase in the volatility index and total return index.
E
Sell
12/2/2024Downgrade
ENDRA Life Sciences Inc. (NDRA) was downgraded to E from E+ on 12/2/2024 due to a noticeable decline in the volatility index and total return index.
ENDRA Life Sciences Inc. (NDRA) was downgraded to E from E+ on 12/2/2024 due to a noticeable decline in the volatility index and total return index.
E
Sell
4/4/2023Downgrade
ENDRA Life Sciences Inc. (NDRA) was downgraded to E+ from D- on 4/4/2023 due to a decline in the volatility index.
ENDRA Life Sciences Inc. (NDRA) was downgraded to E+ from D- on 4/4/2023 due to a decline in the volatility index.
D
Sell
3/20/2023Upgraded
ENDRA Life Sciences Inc. (NDRA) was upgraded to D- from E+ on 3/20/2023 due to an increase in the total return index, volatility index and growth index. Operating cash flow increased 4.87% from -$3.25M to -$3.09M, earnings per share increased from -$1.0891 to -$1.0401, and EBIT increased 3.04% from -$3.42M to -$3.31M.
ENDRA Life Sciences Inc. (NDRA) was upgraded to D- from E+ on 3/20/2023 due to an increase in the total return index, volatility index and growth index. Operating cash flow increased 4.87% from -$3.25M to -$3.09M, earnings per share increased from -$1.0891 to -$1.0401, and EBIT increased 3.04% from -$3.42M to -$3.31M.
E
Sell
3/15/2023Downgrade
ENDRA Life Sciences Inc. (NDRA) was downgraded to E+ from D- on 3/15/2023 due to a decline in the volatility index.
ENDRA Life Sciences Inc. (NDRA) was downgraded to E+ from D- on 3/15/2023 due to a decline in the volatility index.
D
Sell
3/14/2023Downgrade
ENDRA Life Sciences Inc. (NDRA) was downgraded to D- from D on 03/14/2023.
ENDRA Life Sciences Inc. (NDRA) was downgraded to D- from D on 03/14/2023.
D
Sell
2/10/2023Upgraded
ENDRA Life Sciences Inc. (NDRA) was upgraded to D from E+ on 2/10/2023 due to an increase in the volatility index.
ENDRA Life Sciences Inc. (NDRA) was upgraded to D from E+ on 2/10/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
ENDRA Life Sciences Inc. (NDRA) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index and total return index.
ENDRA Life Sciences Inc. (NDRA) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index and total return index.
D
Sell
1/25/2023Downgrade
ENDRA Life Sciences Inc. (NDRA) was downgraded to D- from D on 1/25/2023 due to a decline in the volatility index and total return index.
ENDRA Life Sciences Inc. (NDRA) was downgraded to D- from D on 1/25/2023 due to a decline in the volatility index and total return index.
D
Sell
12/23/2022Upgraded
ENDRA Life Sciences Inc. (NDRA) was upgraded to D from D- on 12/23/2022 due to an increase in the valuation index.
ENDRA Life Sciences Inc. (NDRA) was upgraded to D from D- on 12/23/2022 due to an increase in the valuation index.
D
Sell
12/8/2022Downgrade
ENDRA Life Sciences Inc. (NDRA) was downgraded to D- from D on 12/8/2022 due to a decline in the valuation index.
ENDRA Life Sciences Inc. (NDRA) was downgraded to D- from D on 12/8/2022 due to a decline in the valuation index.
D
Sell
8/2/2022Upgraded
ENDRA Life Sciences Inc. (NDRA) was upgraded to D from D- on 8/2/2022 due to an increase in the volatility index.
ENDRA Life Sciences Inc. (NDRA) was upgraded to D from D- on 8/2/2022 due to an increase in the volatility index.
D
Sell
7/18/2022Downgrade
ENDRA Life Sciences Inc. (NDRA) was downgraded to D- from D on 7/18/2022 due to a decline in the solvency index, total return index and volatility index. The quick ratio declined from 6.13 to 5.25.
ENDRA Life Sciences Inc. (NDRA) was downgraded to D- from D on 7/18/2022 due to a decline in the solvency index, total return index and volatility index. The quick ratio declined from 6.13 to 5.25.
D
Sell
5/16/2022Upgraded
ENDRA Life Sciences Inc. (NDRA) was upgraded to D from E+ on 05/16/2022.
ENDRA Life Sciences Inc. (NDRA) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
ENDRA Life Sciences Inc. (NDRA) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
ENDRA Life Sciences Inc. (NDRA) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
D
Sell
5/5/2022Upgraded
ENDRA Life Sciences Inc. (NDRA) was upgraded to D from D- on 05/05/2022.
ENDRA Life Sciences Inc. (NDRA) was upgraded to D from D- on 05/05/2022.
D
Sell
4/20/2022Downgrade
ENDRA Life Sciences Inc. (NDRA) was downgraded to D- from D on 4/20/2022 due to a substantial decline in the total return index, growth index and solvency index. The quick ratio declined from 7.48 to 6.13, EBIT declined 15.88% from -$2.65M to -$3.07M, and earnings per share declined from -$0.0634 to -$0.0734.
ENDRA Life Sciences Inc. (NDRA) was downgraded to D- from D on 4/20/2022 due to a substantial decline in the total return index, growth index and solvency index. The quick ratio declined from 7.48 to 6.13, EBIT declined 15.88% from -$2.65M to -$3.07M, and earnings per share declined from -$0.0634 to -$0.0734.
D
Sell
11/9/2021Upgraded
ENDRA Life Sciences Inc. (NDRA) was upgraded to D from E+ on 11/9/2021 due to an increase in the valuation index.
ENDRA Life Sciences Inc. (NDRA) was upgraded to D from E+ on 11/9/2021 due to an increase in the valuation index.
E
Sell
11/8/2021Downgrade
ENDRA Life Sciences Inc. (NDRA) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index.
ENDRA Life Sciences Inc. (NDRA) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index.
D
Sell
1/19/2021Upgraded
ENDRA Life Sciences Inc. (NDRA) was upgraded to D from D- on 1/19/2021 due to an increase in the volatility index, total return index and solvency index. The quick ratio increased from 0.6 to 2.71, and debt to equity declined from 0.74 to 0.12.
ENDRA Life Sciences Inc. (NDRA) was upgraded to D from D- on 1/19/2021 due to an increase in the volatility index, total return index and solvency index. The quick ratio increased from 0.6 to 2.71, and debt to equity declined from 0.74 to 0.12.
D
Sell
8/14/2020None
ENDRA Life Sciences Inc. (NDRA) was downgraded to D- from U on 08/14/2020.
ENDRA Life Sciences Inc. (NDRA) was downgraded to D- from U on 08/14/2020.
NASDAQ
03/12/2025 3:39PM Eastern
Quotes delayed
